SCHEMBL7877587

SCHEMBL7877587

CN(C(=N)N)C(=O)c1cc2c(C(F)(F)F)cc(Oc3cncc(N)c3)cc2[nH]1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 1/20 0.33
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884312 0.88 RHEB (0.32) RHEB
SCHEMBL7873257 0.88 ALDH1A1 (0.34) RHEB
SCHEMBL7884760 0.88 RHEB (0.33) RHEB
SCHEMBL7877441 0.87 RHEB (0.39) RHEBAR
SCHEMBL7880736 0.86 SMN1; SMN2 (0.39) RHEB
SCHEMBL7882095 0.86 RHEB (0.37) RHEBAR
SCHEMBL7880774 0.86 RHEB (0.32) RHEB
SCHEMBL7873735 0.86 RHEB (0.36) RHEBAR
SCHEMBL7878038 0.85 RHEB (0.32) RHEB
SCHEMBL7881897 0.84 RHEB (0.40) RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed